
Executives at Microsoft are pledging the company’s new video game app store will be governed by open-market principals, the Wall Street Journal reported Wednesday (Feb. 9).
These remarks were made to reporters ahead of meetings between Microsoft and lawmakers about the company’s landmark purchase of gaming giant Activision Blizzard, reported PYMNTS.
Among the principles the company pledges to adopt for its store: developers won’t need to use a proprietary, something Apple has been criticized for by lawmakers and developers alike.
“We are more focused on adapting to regulation than fighting against it,” said Microsoft President Brad Smith.
Last month, Microsoft announced plans to acquire Activision for $75 billion, its largest purchase ever and a deal that would help bolster the company’s subscription gaming service Game Pass. The service gives users access to a catalog of games for a monthly fee. These users would get to play wildly popular franchises like Call of Duty and World of Warcraft if the deal goes forward.
As many observers have pointed out, the deal is also Microsoft’s bet on the burgeoning metaverse, a 3D world of immersive activities that mix with virtual reality (VR) and augmented reality (AR).
The deal is subject to regulatory approval, with the US Federal Trade Commission trying to determine if the acquisition will hamper competition in the gaming world.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas